The Food and Drug Administration advisory panel is holding a second day of meetings on whether to loosen restrictions on certain unapproved peptide drugs. The panel voted Thursday to broaden access to four peptides. KFF Health News' Amy Maxmen has more.
FDA panel considers loosening regulations on certain unapproved peptides
Full Article
Original Source
Read the full article at Cbsnews →KhanList aggregates and links to publicly available news content. We do not host full articles from third-party sources. Always verify important information with original sources.